MENU ABOUT US MAKE A DONATION
The Epoch Times
Login
SEARCH
CLOSE
Help Center subscribe newsletter Newsstands Epoch Shop Gift
  • TOP NEWS
  • SPECIAL SERIES
  • SPECIAL COVERAGE
  • LATEST ARTICLES
  • US
    • US News
    • US Features
    • US Politics
    • US Crime News
    • New York
    • San Francisco
    • Los Angeles
  • Opinion
    • Thinking About China
    • Viewpoints
    • Unbridled Evil: The Corrupt Reign of Jiang Zemin in China
    • The Reader’s Turn
  • China News
    • US-China Relations
    • Chinese Regime
    • Business & Economy
    • Chinese Culture
    • China Human Rights
    • Social Issues
    • Organ Harvesting in China
  • World News
    • Africa News
    • Americas
    • Asia & Pacific
    • Canada
    • Europe
    • UK News
    • Australia News
    • International
    • Middle East
  • Business & Markets
    • Companies
    • Economy
    • Markets
    • Real Estate
    • Gold and Commodities
  • ARTS & CULTURE
    • Fine Arts & Craftsmanship
    • Performing Arts
    • Books
    • Traditional Culture
    • Shen Yun Special Coverage
    • Film & TV
  • Science
    • News
    • Space
    • Environment
  • Tech
    • Tech News
    • Tech Products & Reviews
    • Social Media
  • Sports
  • Videos
    • American Thought Leaders
    • China Insider
    • Crossroads
  • Bright
    • Lifestyle
    • Inspired
    • Family & Education
    • Personal Finance
    • American Essence
  • Entertainment
    • Film & TV
    • Entertainment News
  • Health
    • Experts
    • Conditions
    • Life & Wellness
  • Special Topics
    • Battlefields
SEARCH
  • EpochTV
  • US
  • US Politics
  • Opinion
  • World News
  • China
  • Hong Kong
  • Health
  • Bright
  • Arts
  • Falun Gong
  • Premium
  • Markets
  • Games
  • Livestream
  • More

Mounjaro

  • Over 700 Drugs More Expensive in 2024, Including Ozempic and Mounjaro
    Over 700 Drugs More Expensive in 2024, Including Ozempic and Mounjaro
    To start 2024, prices hikes on hundreds of drugs are up 22 percent, but record cost savings are expected for Medicaid 
    January 22, 2024BY A.C. Dahnke
  • Eli Lilly to Sell Weight Loss Drugs Directly to Patients
    Eli Lilly to Sell Weight Loss Drugs Directly to Patients
    The platform offers access to Mounjaro and Zepbound by connecting patients with telehealth professionals for evaluation.
    January 8, 2024BY A.C. Dahnke
  • FDA Investigating Reports of Alopecia and Suicidal Ideation as Possible Weight-Loss Drug Side Effects
    FDA Investigating Reports of Alopecia and Suicidal Ideation as Possible Weight-Loss Drug Side Effects
    The FDA is also investigating reported side effects of aspiration.
    January 4, 2024BY A.C. Dahnke
  • How Effective is Weight-Loss Medication vs. Supplements? New Phase of Weight-Loss Meds | Feat. Dr. Damon Noto
    How Effective is Weight-Loss Medication vs. Supplements? New Phase of Weight-Loss Meds | Feat. Dr. Damon Noto
    Dr. Damon Noto discusses the pros and cons of weight loss drugs Ozempic and Mounjaro on VitalSigns.
    October 20, 2023BY Brendon Fallon
  • Diabetes Drug Manufacturers Sued by Woman Who Claims She Suffered ‘Severe Gastrointestinal Events’
    Diabetes Drug Manufacturers Sued by Woman Who Claims She Suffered ‘Severe Gastrointestinal Events’
    The manufacturers of diabetes drugs Ozempic and Mounjaro have been sued by a Louisiana woman who claims they failed to adequately ...
    August 3, 2023BY Katabella Roberts
  • UK Public Agency Won’t Recommend Weight Loss Drug Mounjaro, Needs More Evidence
    UK Public Agency Won’t Recommend Weight Loss Drug Mounjaro, Needs More Evidence
    UK's health and social care watchdog has decided against recommending Mounjaro, Eli Lilly's weight loss drug for adults with diabetes. ...
    June 28, 2023BY Harry Lee
  • Diabetes Drug Shown to Effectively Trim Fat With Minimal Muscle Loss: Study
    Diabetes Drug Shown to Effectively Trim Fat With Minimal Muscle Loss: Study
    Based on a recent analysis, Mounjaro, an approved medication for Type 2 diabetes, has shown promise in reducing ...
    May 31, 2023BY Harry Lee
TOP NEWS
  • Appeals Court Questions Judge’s ‘Intrusive’ Order on RFK Jr. Appointments
    NEW By Zachary Stieber
    Appeals Court Questions Judge’s ‘Intrusive’ Order on RFK Jr. Appointments
  • Trump Says He Will ‘Certainly Look at’ Establishing a US Base in Lithuania
    1hr By Victoria Friedman
    Trump Says He Will ‘Certainly Look at’ Establishing a US Base in Lithuania
  • US Military Disputes Iranian Claim of Downed Helicopter
    2hr By Jack Phillips
    US Military Disputes Iranian Claim of Downed Helicopter
  • California Realtor Accused of Spying for China Appears in Court
    2hr By Arthur Zhang
    California Realtor Accused of Spying for China Appears in Court
  • EXCLUSIVE: AG Blanche on DOJ Strategy to Combat Voter Fraud, Birth Tourism, and Chinese Espionage
    2hr By Jan Jekielek, Epoch TV
    EXCLUSIVE: AG Blanche on DOJ Strategy to Combat Voter Fraud, Birth Tourism, and Chinese Espionage
  • Border Officers Intercept Large Cocaine Smuggling Attempt in Texas
    2hr By Troy Myers
    Border Officers Intercept Large Cocaine Smuggling Attempt in Texas
  • Wall Street Posts Record $45.9 Billion Profit in Standout 1st Half
    4hr By Andrew Moran
    Wall Street Posts Record $45.9 Billion Profit in Standout 1st Half
  • Trump to Tout $6.6 Billion Defense Investment During Baltimore Visit
    4hr By Emel Akan
    Trump to Tout $6.6 Billion Defense Investment During Baltimore Visit
  • What Is the Pneumonic Plague and How Dangerous Is It?
    5hr By Jack Phillips
    What Is the Pneumonic Plague and How Dangerous Is It?
  • US Demands More Transparency From Russia Over Plague Reports
    5hr By Jack Phillips
    US Demands More Transparency From Russia Over Plague Reports
The Epoch Times
Copyright © 2000 - 2026 The Epoch Times Association Inc. All Rights Reserved.
Back Top